Skip to main content

Green Star Products Releases COVID-19 Efficacy Data

SALT LAKE CITY, UT, May 21, 2021 (GLOBE NEWSWIRE) — Green Star Products, Inc.’s (US OTC: GSPI) new president, Kristy Hunt, today released the successful Viro Spectrum Shield (VSS) efficacy data concerning the COVID-19 virus. More importantly, President Hunt has decided to release, for the first time, the credentials of the Federally Accredited Laboratory that completed the testing program because of the dire situation in India, the Philippines, and some countries in South America, including Brazil. 

President Hunt has initiated a humanitarian program to deliver thousands of bottles of Viro Spectrum Shield (VSS) to help people in these affected countries at no cost to them. In order to move forward with her program and fast track the delivery of Viro Spectrum Shield, through humanitarian channels, it is now necessary to establish the credentials of the testing facility and provide their results. 

The successful efficacy testing was completed by the renowned Midwest Research Institute (MRIGlobal.org) a United States Federally Accredited Laboratory, which also runs operations for the U. S. Department of Defense and U. S. Department of Energy. 

MRIGlobal’s objective in 2020 was to determine if Viro Spectrum Shield had the ability to inhibit cellular infection in vitro by SARS-CoV-2 virus (the virus for COVID-19). The multifaceted testing program included: a) using Viro Spectrum Shield as a preventative before infection, b) as a treatment after infection, c) at a variety of different doses down to 10% strength, and d) test and report on toxicity. The results indicated an efficacy of 99.9% of VSS as a pre-treatment, and 93% efficacy after infection. Even at low dosage levels VSS had efficacy. VSS was reported as non-toxic under in vitro conditions. The final conclusion of the MRIGlobal report was that in vitro Viro Spectrum Shield inhibits SARS-CoV-2. (See attached Official MRIGlobal Statement Report Information). 

Human Volunteer Testing: Simultaneous with the MRIGlobal testing program, throughout the year 2020 and into 2021, extremely sick human volunteers, many of whom tested positive for SARS-CoV-2 virus decided to take VSS with the following results: 

– All VSS testing volunteers recovered quickly from their painful symptoms and respiratory problems, many within 24 to 48 hours. 

-No VSS testing volunteers required hospitalization or died. No one experienced any side effects or negative reactions. See testimonials at https://vssmt.net/

VSS had been tested before by MRIGlobal. In 2009, MRIGlobal also completed successful testing on the “PEY” (now called Viro Spectrum Shield) antiviral formula against three additional infectious viruses, specifically A/H1N1, A/H2N3, and B/H2N3. MRIGlobal’s research found VSS to have efficacy against all three viruses. All testing was paid by private funding. 

Ms. Hunt has donated the first 1000 bottles, free of charge, through her nonprofit organization Kristy Hunt Homeopathic Research Foundation (https://khhrf.com/). The bottles were paid for through donations to the nonprofit organization and will be distributed through Green Star Products’ distribution channels. Also, Biotech Research, LLC, the manufacturer of Viro Spectrum Shield, played an important role by making these bottles available to the foundation at a very low cost. 

A&P Distributors LLC (https://www.apdistributor.com/), with headquarters in the Metro Center of Manila in the Philippines and Hawaii is also playing a key role in this humanitarian effort and has major clients and distributors in 23 Pacific Rim countries. Please see press release dated April 29, 2021, titled “GreenStar Products Signs Distribution Contract for Pacific Rim Countries. (https://gspiusa.com/press-release

VIRO SPECTRUM SHIELD is a blend of natural herbs (flavonoids and ligands) and ascorbic acid in a vegan capsule. VSS contains no caffeine, fillers, yeast, artificial flavors or colors, or added sodium. Kosher Certified. 500 mg per capsule. VSS is classified as a dietary supplement, therefore it does not need FDA approval. See https://vssmt.net/ for more information and testimonials (use coupon code PR521 at check out). 

About Green Star Products 

Green Star Products, Inc. (PINKSHEETS: GSPI) is an environmentally friendly Public Company creating innovative and cost-effective products to improve the quality of life and the environment. For more information, please go to our website https://gspiusa.com/ 

Forward-looking statements are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such statements involve risks and uncertainties, including without limitation, continued acceptance of the Company’s products, its dependence on third-party suppliers, and other risks detailed from time to time in the Company’s periodic filings. 

CONTACT:

Kristy Hunt, President
Green Star Products, Inc.
kristy@gspiusa.com 
https://gspiusa.com/

Official MRIGlobal Statement Attachment On Next Page

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.